Germano and colleagues recently demonstrated that inactivation of the mismatch repair gene MutL homologue 1 (MLH1) in murine colorectal cancer cell lines increased the susceptibility of transplanted tumours derived from these cells to immune surveillance and CPI therapy compared with tumours derived from parental cells [153]. The gene discussed is MLH1; the disease is neoplasm.